L-阿拉伯糖

GI(Glucose = 100)

0^*0^*

Energy(kcal/100g)

—

還沒有來源收錄。

Carbs(g/100g)

—

還沒有來源收錄。

Sugars(g/100g)

—

還沒有來源收錄。

功能性益處

• 與蔗糖同時食用時可抑制蔗糖酶

  Krog-Mikkelsen 2011 (AJCN): uncompetitive sucrase block in vitro; with sucrose drinks in healthy men, lower glucose/insulin peaks and higher GLP-1. Seri 1996 established selective sucrase inhibition in animals. Works only with co-ingested sucrose — not a free pass to unlimited sugar.

  Krog-Mikkelsen et al. — L-arabinose sucrase inhibition dose-response in vitro and in humans (Am J Clin Nutr) (2011)

已引述的礦物質可在 日常最適合的甜味劑 上最多加 +2 分，見 Methods。

風險與副作用

• 與蔗糖同時食用時可能引起滲透性腸胃不適

  caution

  GI discomfort reported when taken with sucrose. Not a medical diagnosis. Scored: −7 on Everyday Health, Diabetic-friendly and Minimally processed — no symptom-free single dose on file, so the 75th percentile of rows with one (missing is not clean).

  Pasmans et al. — L-arabinose co-ingestion delays glucose absorption from sucrose (Br J Nutr) (2021)

這不是醫療建議。若該項目會依公開公式扣分，細節列在「分數怎麼算」；分數不代表臨床嚴重程度。

註記

• Works as a sucrose companion (sucrase block), not a full sugar swap. Keep real sucrose when you need caramelization — then dose arabinose against that sucrose.

  Editorial kitchen note. Human effect sizes vary by matrix (liquids clearer than complex meals).

  Seri et al. — L-Arabinose selectively inhibits intestinal sucrase (Metabolism) (1996)

• Metabolizable energy for pure L-arabinose is unsettled across sources (sometimes called noncaloric). Left empty rather than inventing kcal/100 g — Everyday stays unranked until a labeling-grade factor is on file.

  找不到可靠資料就留白，不自行推估。

註記說明公開軸或風險標籤本身看不出來的事，不是醫療建議。